Matthias Paschke

746 total citations
10 papers, 602 citations indexed

About

Matthias Paschke is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Matthias Paschke has authored 10 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Oncology. Recurrent topics in Matthias Paschke's work include Peptidase Inhibition and Analysis (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Matthias Paschke is often cited by papers focused on Peptidase Inhibition and Analysis (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Matthias Paschke collaborates with scholars based in Germany, United States and Switzerland. Matthias Paschke's co-authors include Jasmine Onderka, Claus Cursiefen, Felix Bock, Grit Zahn, Tina Dietrich-Ntoukas, Björn Bachmann, Friedrich E. Kruse, Wolfgang Höhne, Michael Hust and Thomas Schirrmann and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Annals of Oncology.

In The Last Decade

Matthias Paschke

10 papers receiving 584 citations

Peers

Matthias Paschke

RNMI

ONCOL

ECOLO

OPHTH

Christopher Agnew United States

Joseph Z. Zaretsky Israel

Dody Avichezer Israel

Hok Seon Kim United States

Andrea Naranjo United States

Zhilan Zeng United States

Mónica Vicente-Pascual Spain

Fulvia Troise Italy

Stefan Seeber Switzerland

Christopher Agnew United States

Matthias Paschke

62 ×0.2

RNMI

318 ×1.0

118 ×1.1

ONCOL

31 ×0.3

ECOLO

6 ×0.1

OPHTH

Citations per year, relative to Matthias Paschke Matthias Paschke (= 1×) peers Christopher Agnew

Countries citing papers authored by Matthias Paschke

Since Specialization

Citations

This map shows the geographic impact of Matthias Paschke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Paschke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Paschke more than expected).

Fields of papers citing papers by Matthias Paschke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Paschke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Paschke. The network helps show where Matthias Paschke may publish in the future.

Co-authorship network of co-authors of Matthias Paschke

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Paschke. A scholar is included among the top collaborators of Matthias Paschke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Paschke. Matthias Paschke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Wiedemann, Norbert, Aileen Hoehne, Frank Osterkamp, et al.. (2024). Preclinical Characterization of DPI-4452: A⁶⁸Ga/¹⁷⁷Lu Theranostic Ligand for Carbonic Anhydrase IX. Journal of Nuclear Medicine. 65(5). 761–767. 16 indexed citations

Zboralski, Dirk, Aileen Hoehne, Matthias Paschke, et al.. (2022). Abstract 3317: Comparative biodistribution and radiotherapeutic efficacy of the fibroblast activation protein (FAP)-targeting agents FAP-2286 and FAPI-46. Cancer Research. 82(12_Supplement). 3317–3317. 4 indexed citations

Kwan, Tanya T., Minh Nguyen, Dirk Zboralski, et al.. (2021). Abstract LBA032: Pan-cancer analysis of fibroblast activation protein alpha (FAP) expression to guide tumor selection for the peptide-targeted radionuclide therapy FAP-2286. Molecular Cancer Therapeutics. 20(12_Supplement). LBA032–LBA032. 4 indexed citations

Zboralski, Dirk, Frank Osterkamp, Andrew D. Simmons, et al.. (2020). 571P Preclinical evaluation of FAP-2286, a peptide-targeted radionuclide therapy (PTRT) to fibroblast activation protein alpha (FAP). Annals of Oncology. 31. S488–S488. 14 indexed citations

Gibson, Christoph, Karsten Schnatbaum, Elsa Locardi, et al.. (2009). Novel Small Molecule Bradykinin B ₂ Receptor Antagonists. Journal of Medicinal Chemistry. 52(14). 4370–4379. 21 indexed citations

Thie, Holger, Thomas Schirrmann, Matthias Paschke, Stefan Dübel, & Michael Hust. (2008). SRP and Sec pathway leader peptides for antibody phage display and antibody fragment production in E. coli. New Biotechnology. 25(1). 49–54. 61 indexed citations

Paschke, Matthias, Christian Tiede, & Wolfgang Höhne. (2007). Engineering a circularly permuted GFP scaffold for peptide presentation. Journal of Molecular Recognition. 20(5). 367–378. 5 indexed citations

Bock, Felix, Jasmine Onderka, Tina Dietrich-Ntoukas, et al.. (2007). Bevacizumab as a Potent Inhibitor of Inflammatory Corneal Angiogenesis and Lymphangiogenesis. Investigative Ophthalmology & Visual Science. 48(6). 2545–2545. 277 indexed citations

Paschke, Matthias. (2005). Phage display systems and their applications. Applied Microbiology and Biotechnology. 70(1). 2–11. 153 indexed citations

10.

Paschke, Matthias & Wolfgang Höhne. (2005). A twin-arginine translocation (Tat)-mediated phage display system. Gene. 350(1). 79–88. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact